Cargando…
One dose of immunotherapy leading to an exceptional and durable response in a patient with metastatic renal cell carcinoma
A 72-year-old man with metastatic clear cell renal carcinoma, who had progressed after previous treatment with Sunitinib and Axitinib, was given one dose of immunotherapy. He was initially unwell after treatment with fever, shortness of breath, chest pain and raised inflammatory markers. Following t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937447/ https://www.ncbi.nlm.nih.gov/pubmed/31908826 http://dx.doi.org/10.1093/omcr/omz128 |